# SERPINB6

## Overview
SERPINB6 is a gene that encodes the protein serpin family B member 6, which is a member of the serpin superfamily of serine protease inhibitors. This protein is primarily involved in regulating protease activity within cells, thereby maintaining cellular homeostasis and protecting against protease-induced damage. SERPINB6 is predominantly localized in the cytoplasm of various cell types, including endothelial and epithelial cells, as well as immune cells such as monocytes and neutrophils. The protein's structure, characterized by a conserved serpin fold with a reactive center loop, enables it to inhibit serine proteases like cathepsin G, β-tryptase, and thrombin. This inhibition is crucial for preventing cellular damage and is implicated in processes such as inflammation, tumor progression, and cell death (Jang2021Dutomycin; Silverman2001The; Gatto2013Serpins).

## Structure
SERPINB6 is a member of the serpin superfamily, characterized by a conserved structure essential for its function as a serine protease inhibitor. The primary structure of SERPINB6 consists of a sequence of amino acids forming a polypeptide chain, which is organized into a secondary structure comprising several alpha-helices and beta-sheets (Silverman2001The; Gatto2013Serpins). The tertiary structure of serpins, including SERPINB6, involves a metastable conformation necessary for their inhibitory activity. This structure includes three beta-sheets and eight or nine alpha-helices, with a reactive center loop (RCL) that plays a crucial role in the inhibitory mechanism by interacting with target proteases (Silverman2001The; Gatto2013Serpins).

The RCL is a flexible region that undergoes significant structural rearrangements upon binding with a protease, leading to a conformational change that inactivates the protease (Silverman2001The). SERPINB6, like other ov-serpins, lacks an N-terminal signal peptide, indicating its primary intracellular localization (Gatto2013Serpins). The protein's structure allows it to inhibit serine proteases such as cathepsin G, β-tryptase, and thrombin, contributing to its role in protecting cells from lysosomal injury (Jang2021Dutomycin). The molecular structure of SERPINB6 is crucial for its function in various biological processes, including tumor progression, inflammation, and cell death (Kaiserman2002Comparison).

## Function
SERPINB6 is a serine protease inhibitor that plays a crucial role in maintaining cellular homeostasis by regulating protease activity. It is primarily active in the cytoplasm of endothelial cells, epithelial cells, monocytes, and neutrophils. SERPINB6 inhibits several serine proteases, including cathepsin G, β-tryptase, kallikrein-2, kallikrein-8, and thrombin, by forming stable complexes with these enzymes. This inhibition is essential for preventing cellular damage and maintaining cellular homeostasis, particularly by protecting cells from damage caused by protease leakage from lysosomes (Jang2021Dutomycin).

In healthy cells, SERPINB6 contributes to cytoprotection and defense against lysosomal injury, which is crucial for cellular survival and function. It is involved in preventing cell death and inflammation, thereby playing a protective role in various tissues (Jang2021Dutomycin). The protein's activity is significant in the context of its interaction with intracellular serine proteases, where it helps to regulate processes such as autophagy and apoptosis. This regulation is vital for maintaining cellular integrity and preventing excessive protease activity that could lead to cellular damage (Jang2021Dutomycin).

## Clinical Significance
Mutations and altered expression of the SERPINB6 gene have been implicated in various diseases and conditions. In glioblastoma multiforme (GBM), a type of brain cancer, higher expression levels of SERPINB6 are significantly associated with disease progression, as indicated by a hazard ratio of 1.44, suggesting a worse progression outcome for patients with elevated SERPINB6 expression (AlKhatib2024Exploring). This highlights the potential role of SERPINB6 in promoting tumor progression and metastasis in cancer biology (AlKhatib2024Exploring).

SERPINB6 also plays a critical role in preventing programmed necrosis in neutrophils and monocytes by inhibiting Cathepsin G, a serine protease. Deficiency in SERPINB6 can lead to increased inflammation and cell death, particularly through the activation of gasdermin D, which contributes to cell lysis and inflammation (Burgener2019Cathepsin). This suggests that alterations in SERPINB6 expression or function could enhance inflammation and susceptibility to infections (Burgener2019Cathepsin).

While the context does not directly mention specific diseases associated with SERPINB6 mutations, its role in inflammation and cancer progression indicates its clinical significance in these areas. Further research is needed to fully understand the implications of SERPINB6 alterations in various diseases.

## Interactions
SERPINB6, a member of the serpin family, is known for its interactions with various serine proteases, playing a crucial role in inhibiting their proteolytic activities. One of its primary interactions is with cathepsin G, a serine protease involved in immune responses. SERPINB6 binds to cathepsin G, forming a stable complex that inhibits the protease's activity, thereby preventing potential cellular damage (Scott1999The). This interaction is significant in monocytes and granulocytes, where SERPINB6 regulates cathepsin G to maintain cellular homeostasis (Scott1999The).

SERPINB6 also interacts with other serine proteases, such as β-tryptase, kallikrein-2, kallikrein-8, and thrombin, by forming SDS-stable complexes, which inhibit their activity (Jang2021Dutomycin). These interactions are essential for controlling protease activity within cells and preventing excessive proteolysis.

In addition to its role in protease inhibition, SERPINB6 is a target of the compound Dutomycin (DTM). DTM binds directly to SERPINB6, disrupting its function and leading to increased intracellular serine protease activity. This interaction is linked to the induction of autophagy and apoptosis in cancer cells, highlighting SERPINB6's involvement in cellular processes beyond protease inhibition (Jang2021Dutomycin).


## References


[1. (Kaiserman2002Comparison) Dion Kaiserman, Susan Knaggs, Katrina L Scarff, Anneliese Gillard, Ghazala Mirza, Matthew Cadman, Richard McKeone, Paul Denny, Jessica Cooley, Charaf Benarafa, Eileen Remold-O’Donnell, Jiannis Ragoussis, and Phillip I Bird. Comparison of human chromosome 6p25 with mouse chromosome 13 reveals a greatly expanded ov-serpin gene repertoire in the mouse. Genomics, 79(3):349–362, March 2002. URL: http://dx.doi.org/10.1006/GENO.2002.6716, doi:10.1006/geno.2002.6716. This article has 71 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/GENO.2002.6716)

[2. (Burgener2019Cathepsin) Sabrina Sofia Burgener, Nathan Georges François Leborgne, Scott J. Snipas, Guy S. Salvesen, Phillip Ian Bird, and Charaf Benarafa. Cathepsin g inhibition by serpinb1 and serpinb6 prevents programmed necrosis in neutrophils and monocytes and reduces gsdmd-driven inflammation. Cell Reports, 27(12):3646-3656.e5, June 2019. URL: http://dx.doi.org/10.1016/j.celrep.2019.05.065, doi:10.1016/j.celrep.2019.05.065. This article has 187 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2019.05.065)

[3. (Scott1999The) Fiona L. Scott, Claire E. Hirst, Jiuru Sun, Catherina H. Bird, Stephen P. Bottomley, and Phillip I. Bird. The intracellular serpin proteinase inhibitor 6 is expressed in monocytes and granulocytes and is a potent inhibitor of the azurophilic granule protease, cathepsin g. Blood, 93(6):2089–2097, March 1999. URL: http://dx.doi.org/10.1182/blood.v93.6.2089.406k10_2089_2097, doi:10.1182/blood.v93.6.2089.406k10_2089_2097. This article has 68 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood.v93.6.2089.406k10_2089_2097)

[4. (AlKhatib2024Exploring) Sohaib M. Al-Khatib, Ayah N. Al-Bzour, Mohammad N. Al-Majali, Laila M. Sa’d, Joud A. Alramadneh, Nour R. Othman, Abdel-Hameed Al-Mistarehi, and Safwan Alomari. Exploring genetic determinants: a comprehensive analysis of serpin b family snps and prognosis in glioblastoma multiforme patients. Cancers, 16(6):1112, March 2024. URL: http://dx.doi.org/10.3390/cancers16061112, doi:10.3390/cancers16061112. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers16061112)

[5. (Gatto2013Serpins) Mariele Gatto, Luca Iaccarino, Anna Ghirardello, Nicola Bassi, Patrizia Pontisso, Leonardo Punzi, Yehuda Shoenfeld, and Andrea Doria. Serpins, immunity and autoimmunity: old molecules, new functions. Clinical Reviews in Allergy &amp; Immunology, 45(2):267–280, January 2013. URL: http://dx.doi.org/10.1007/s12016-013-8353-3, doi:10.1007/s12016-013-8353-3. This article has 87 citations.](https://doi.org/10.1007/s12016-013-8353-3)

[6. (Silverman2001The) Gary A. Silverman, Phillip I. Bird, Robin W. Carrell, Frank C. Church, Paul B. Coughlin, Peter G.W. Gettins, James A Irving, David A. Lomas, Cliff J. Luke, Richard W. Moyer, Philip A. Pemberton, Eileen Remold-O’Donnell, Guy S. Salvesen, James Travis, and James C. Whisstock. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Journal of Biological Chemistry, 276(36):33293–33296, September 2001. URL: http://dx.doi.org/10.1074/jbc.r100016200, doi:10.1074/jbc.r100016200. This article has 964 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.r100016200)

[7. (Jang2021Dutomycin) Mina Jang, Shuta Hara, Gun-Hee Kim, Seung Min Kim, Sangkeun Son, Mincheol Kwon, In-Ja Ryoo, Hyemin Seo, Min Jung Kim, Nam-Doo Kim, Nak-Kyun Soung, Yong Tae Kwon, Bo Yeon Kim, Hiroyuki Osada, Jae-Hyuk Jang, Sung-Kyun Ko, and Jong Seog Ahn. Dutomycin induces autophagy and apoptosis by targeting the serine protease inhibitor serpinb6. ACS Chemical Biology, 16(2):360–370, February 2021. URL: http://dx.doi.org/10.1021/acschembio.0c00889, doi:10.1021/acschembio.0c00889. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1021/acschembio.0c00889)